Skip to main content

Table 5 Analysis of the correlation between the study variables and MAFLD from NHANES 2007–2016

From: Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database

Characteristic

OR1

95% CI1

p-value

Model1

AGTR

0.31

0.29, 0.33

 < 0.001

AIP

   

 Q1(≤ -0.2824)

—

—

 

 Q2(-0.2824, -0.0687)

2.66

2.17, 3.26

 < 0.001

 Q3(-0.0687,0.1634)

6.16

5.08, 7.46

 < 0.001

 Q4(> 0.1634)

16.7

13.3, 21.0

 < 0.001

Model2

AGTR

0.30

0.28, 0.32

 < 0.001

AIP

   

 Q1(≤ -0.2824)

—

—

 

 Q2(-0.2824, -0.0687)

2.56

2.11, 3.12

 < 0.001

 Q3(-0.0687,0.1634)

5.88

4.86, 7.11

 < 0.001

 Q4(> 0.1634)

16.3

13.0, 20.5

 < 0.001

Model3

AGTR

0.30

0.27, 0.33

 < 0.001

AIP

   

 Q1(≤ -0.2824)

—

—

 

 Q2(-0.2824, -0.0687)

1.81

1.35, 2.44

 < 0.001

 Q3(-0.0687,0.1634)

3.32

2.61, 4.21

 < 0.001

 Q4(> 0.1634)

7.27

5.47, 9.65

 < 0.001

  1. Model1 No variables were adjusted
  2. Model2 Adjusted for age, gender, race, and income poverty ratio
  3. Model3 Adjusted for BMI, physical activity, diabetes mellitus, alkaline phosphatase, mercury, cadmium, transaminases, smoking, drinking, protein intake, vitamin C and potential confounders of LDL on a previous basis based on model2
  4. AGTR albumin to glutamyl transpeptidase ratio, AIP plasma atherogenicity index
  5. 1OR Odds Ratio, CI Confidence Interval
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us